Mairs & Power Inc’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17,236
Closed -$1.75M 251
2025
Q4
$1.75M Sell
17,236
-76,001
-82% -$6.1M 0.02% 126
2025
Q3
$5.1M Buy
93,237
+18,762
+25% +$937K 0.05% 94
2025
Q2
$3.96M Buy
74,475
+12,780
+21% +$649K 0.04% 101
2025
Q1
$2.67M Buy
61,695
+1,285
+2% +$65.1K 0.03% 106
2024
Q4
$3.39M Buy
60,410
+16,700
+38% +$1.04M 0.03% 100
2024
Q3
$2.98M Buy
43,710
+5,185
+13% +$293K 0.03% 104
2024
Q2
$1.63M Buy
38,525
+14,620
+61% +$804K 0.02% 118
2024
Q1
$1.65M Buy
23,905
+105
+0.4% +$6.64K 0.02% 122
2023
Q4
$1.76M Hold
23,800
0.02% 124
2023
Q3
$1.62M Hold
23,800
0.02% 120
2023
Q2
$2.23M Hold
23,800
0.02% 113
2023
Q1
$1.61M Hold
23,800
0.02% 124
2022
Q4
$1.18M Buy
+23,800
New +$972K 0.01% 134

Other funds holding EXAS

Mairs & Power Inc's EXAS Position: Q1 2026 in Review

Mairs & Power Inc sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 17,236 shares — an estimated $1.75M sold.

Mairs & Power Inc first reported a position in EXAS in Q4 2022 and held it in 13 quarters. The position peaked at $5.1M in Q3 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Mairs & Power Inc reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Mairs & Power Inc sold 17,236 Exact Sciences shares in Q1 2026, an estimated $1.75M.
  • Mairs & Power Inc first reported a position in Exact Sciences in Q4 2022 and held it in 13 quarters.
  • Mairs & Power Inc's Exact Sciences position peaked at $5.1M in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Mairs & Power Inc's 13F filing for Q1 2026, filed 14 May 2026.